rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-4-27
|
pubmed:abstractText |
Since March 2002, the United Network for Organ Sharing liver allocation policy has given extra priority to patients with hepatocellular carcinoma (HCC) who meet specific medical criteria. This study reviews our experience with liver transplantation for HCC under this system.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1879-1190
|
pubmed:author |
pubmed-author:FeunLynn GLG,
pubmed-author:GarciaMonica TMT,
pubmed-author:IslandEddieE,
pubmed-author:LeviDavid MDM,
pubmed-author:LivingstoneAlan SAS,
pubmed-author:MadrazoBeatrice LBL,
pubmed-author:MartinPaulP,
pubmed-author:MoonJangJ,
pubmed-author:NarayananGovindarajanG,
pubmed-author:NishidaSeigoS,
pubmed-author:SelvaggiGennaroG,
pubmed-author:SkartsisNikolaosN,
pubmed-author:TekinAkinA,
pubmed-author:TryphonopoulosPanagiotisP,
pubmed-author:TzakisAndreas GAG
|
pubmed:copyrightInfo |
Copyright 2010 American College of Surgeons. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
210
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
727-34, 735-6
|
pubmed:meshHeading |
pubmed-meshheading:20421039-Adult,
pubmed-meshheading:20421039-Aged,
pubmed-meshheading:20421039-Carcinoma, Hepatocellular,
pubmed-meshheading:20421039-Cohort Studies,
pubmed-meshheading:20421039-Disease-Free Survival,
pubmed-meshheading:20421039-Female,
pubmed-meshheading:20421039-Humans,
pubmed-meshheading:20421039-Liver Neoplasms,
pubmed-meshheading:20421039-Liver Transplantation,
pubmed-meshheading:20421039-Male,
pubmed-meshheading:20421039-Middle Aged,
pubmed-meshheading:20421039-Neoplasm Staging,
pubmed-meshheading:20421039-Patient Selection,
pubmed-meshheading:20421039-Retrospective Studies,
pubmed-meshheading:20421039-Survival Rate,
pubmed-meshheading:20421039-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
|
pubmed:affiliation |
Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
|
pubmed:publicationType |
Journal Article
|